Latest News in the pharma Industry

Market News

Piqur and Pierre Fabre announce partnership in dermato-oncology

Piqur and Pierre Fabre announce partnership in dermato-oncology

11 Jan 2017

Collaboration will give Pierre Fabre the option to enter into exclusive negotiations to license global rights for the program in selected skin cancer conditions.

Read more 
Merck expands end-to-end biodevelopment centers

Merck expands end-to-end biodevelopment centers

10 Jan 2017

Expansionincludes the opening of two new process development centers in the US and China.

Read more 
Pharma predictions for 2017: the good, the bad, and the Donald

Pharma predictions for 2017: the good, the bad, and the Donald

10 Jan 2017

Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities.

Read more 
Innova Biosciences introduces the Conjugate Check&Go! Kit

Innova Biosciences introduces the Conjugate Check&Go! Kit

10 Jan 2017

Scientists can confirm, in one easy step, whether an antibody has been successfully conjugated.

Read more 
Aurobino subsidiary to acquire Generis Farmaceutica

Aurobino subsidiary to acquire Generis Farmaceutica

10 Jan 2017

Generis is the most sold pharmaceutical brand in Portugal, and is the #2 generic group in Portugal.

Read more 
Allergan obatins worldwide rights to microbiome GI development programs

Allergan obatins worldwide rights to microbiome GI development programs

10 Jan 2017

Deal expands Allergan's innovative GI [ipeline with ABI-M201 and ABI-M301, preclinical compounds targeting Uucerative colitis and Crohn's disease, as well as future compounds for irritable bowel syndrome.

Read more 
Takeda and PvP Biologics sign development agreement around novel therapeutic for celiac disease

Takeda and PvP Biologics sign development agreement around novel therapeutic for celiac disease

9 Jan 2017

KumaMax could provide hope celiac patients who try, but are unable to completely avoid gluten exposure in their diets,

Read more 
Catalent to develop softgel capsules for JOT's leading orphan disease candidates

Catalent to develop softgel capsules for JOT's leading orphan disease candidates

9 Jan 2017

JOTROL is being developed to remedy resveratrol’s poor bioavailability and dose limiting gastrointestinal side effects.

Read more 
Cardinal Health reaches $20 million settlement with West Virginia

Cardinal Health reaches $20 million settlement with West Virginia

9 Jan 2017

Company collaborating with all participants in the pharma supply chain to tackle to the epidemic of prescription drug abuse.

Read more 
Ariad to be acquired by Takeda for $5.2 billion

Ariad to be acquired by Takeda for $5.2 billion

9 Jan 2017

Ariad stockholders to receive $24.00 per share in cash.

Read more 
Ascendia Pharmaceuticals awarded new patent on its ASD-002 program for acute coronary syndrome

Ascendia Pharmaceuticals awarded new patent on its ASD-002 program for acute coronary syndrome

9 Jan 2017

A ready-to-use, stable and soluble, parenteral form of clopidogrel is feasible using the company's nanoemulsion platform technology.

Read more 
Lilly to adjust organization and leadership structure

Lilly to adjust organization and leadership structure

5 Jan 2017

Christi Shaw hired to lead Bio-Medicines; Conterno to assume additional geographic responsibilities, including Lilly USA leadership; Zulueta to lead International business.

Read more